First of its kind patient cohort program announced at IPF-Summit
uMed announces the launch of the Access-ILD/PF Cohort which will soon be available to UK and US researchers struggling to recruit patients with interstitial lung disease (ILD).
Finding the Right Patients for Primary Care Clinical Studies
An article published in the Journal of Clinical Studies describing the benefits of uMed in clinical trial recruitment
Automated recruitment platform accelerates patients into clinical studies significantly faster than traditional manual methods
An automated patient recruitment platform (ARP) could help researchers recruit patients significantly faster into clinical studies across diverse disease areas, helping researchers identify new treatments for diseases more quickly, tech platform creator uMed says
Q&A with Dr Matt Wilson, founder, uMed
Great piece from Startups Magazine with our CEO Matt Wilson covering our growth as a health technology company and the importance of building trust with all stakeholders where health data is involved
Three tech start-ups actively fighting coronavirus
Growth Business highlights 3 tech start-ups actively fighting the Covid-19 pandemic that are open for investment to fund further research and development.
uMed raises $4.8m in venture capital funding
uMed raises $4.8m in venture capital funding to help healthcare providers participate in more clinical studies. Funding will enable health tech startup to grow its innovative platform …
Patient privacy is driving the digital healthcare agenda
uMed’s Ian Wootton joined the debate on Integrated Healthcare, hosted by the UKs Department for International Trade at Arab Health.
uMed feature in the 100 HealthTech Pioneers of 2020
We are excited to share uMed are in the Top 20 of the BusinessCloud’s 100 HealthTech Pioneers ranking for 2020! Well done to the uMed team for all their continued hard work!